YES, WE CAN

Our goal is simple, to improve lives by increasing access to medicines around the world.

We deliver solutions for organizations in the global healthcare network, removing barriers and implementing programs so they can:

  • Provide access to medicines for patients in need
  • Demonstrate the value of new medications
  • Enable better health

YES, WE WILL

Our commitment is unwavering.

We relentlessly pursue and deliver the best solutions to enable access, no matter how challenging the situation. We are resourceful and creative and always going the extra mile.

YES, WE DID

The Challenge:

Reduce the risk of infection in leukemia patients.

LEUKINE®, approved by the US FDA in 1991, is a recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) that stimulates the immune system and has been used in leukemia patients to reduce the risk of infection.

In 2018, Partner Therapeutics, Inc. (PTx) acquired the global rights to develop, manufacture, and commercialize Leukine ® (sargramostim) from Sanofi. As a small company, Ptx did not have the internal resources to handle international requests for the drug and didn’t know how they could successfully support patients outside the US, in full regulatory compliance, even though the product was not registered in other geographies.

 

Read More

YES, WE DID

The Challenge:

Provide free cancer treatment to patients around the world

The Max Foundation is a global non-profit organization focused on increasing the access to treatment, care and support for people living with cancer around the world. In 2017 the Foundation sought to put in place The Max Access Solutions program, a patient-centric care model for delivering free cancer treatment to those in need. The Foundation wanted to be able to offer its patients targeted treatment using a portfolio of oncology medicines from multiple pharmaceutical companies. They sought a partner to handle the distribution, quality assurance and regulatory activities to safely and securely store, handle and deliver the medicines to their patients. After evaluating options for a partner to manage the distribution, Tanner was selected.

Read More

YES, WE DID

The Challenge:

Uninterrupted distribution to patients in Latin America

A major pharmaceutical company divested a mature pipeline asset to a medium size pharma company that did not have a presence in Latin America, but wanted to continue distribution of the product.

Read More

YES, WE DID

The Challenge:

Assuring continuity during a global pandemic

A leading clinical-stage biotechnology company required packs of a comparator to conduct a Phase III trial for their leading asset. They required the stock in a single lot, and because of the ongoing COVID-19 pandemic, wanted stock with a long shelf life and additional assurances regarding the supply chain to minimize lead times and the chance of unexpected manufacturer disruptions.

Read More

TESTIMONIAL

Tanner Pharma Group is truly an example of what it means to put humanity at the center of their business. This was not just words on a page or some empty mission statement, it’s compassion in action!

They are a prime example on how Pharma should be running their business and focusing their motivation.

Joshua Frase Foundation

PROVIDING ACCESS TO

120+

countries with the help of our non-profit collaborators:

PROVIDING ACCESS TO

RECENT NEWS & EVENTS

  1. Building a global supply chain network for clinical trial products

    Originally posted on Pharmaceutical Technology. On-time deliveries are paramount in the pharmaceutical world. But ensuring expedited transfer from one location to another is only a piece of the process. Packaging requirements, temperature controls, country-specific transport and storage capabilities, and more must be strictly managed to ensure success. Tanner Pharma Group has established a specialist storage…

    Read More
  2. Protection through preparation: How self-test kits became essential

    Originally posted on Pharmaceutical Technology. The value of self-test kits has surged in the last two years and these items are now viewed as an integral part of the fight against a rise of infectious diseases, from Covid-19 to monkeypox. We learn how Tanner’s GMS division ensures sufficient supply as demand increases. Self-test kits have…

    Read More
  3. Tanner Pharma Group Supports Ukraine

    In response to the ongoing crisis in Ukraine, Tanner Pharma Group will contribute over $124,500 and donate 14,803 units of essential products to select organizations that are making a positive impact and actively providing direct aid and relief to those most affected by Russia’s war in Ukraine. Learn more about the work of these organizations…

    Read More

FEATURE

Max Global Experience: Uganda

Tanner Pharma Group is proud to serve as the title sponsor for The Max Foundation’s 2018 “Max Global Experience: Uganda,” an expedition to raise awareness and funds for increased cancer treatment access in Africa.

Read More

Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group’s Data Privacy Policy. For more information, click here.